Diabetes treatment is constantly progressing, with new therapeutic options appearing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the actions https://tamzinaexn651033.wikipresses.com/6732657/novel_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment